Brief: Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase
22/02/2023 13:53
Feb 22 (Reuters) - Ajinomoto Co Inc 2802.T :
* AJINOMOTO BIO-PHARMA SERVICES SUCCESSFULLY DEVELOPS HIGHLY
FUNCTIONAL ANCESTRAL RNA LIGASE
Source text for Eikon: ID:nPn6XXFK3a
Further company coverage: 2802.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ajinomoto Co
See all newsBrief: Ajinomoto Co Inc - Proposed To Ajinomoto (Malaysia) Berhad About Scr With Offer Price At 20.0 Ringgit Per Share, Total Capital Repayment Will Be 603.4 Million Ringgit (24.2 Billion Yen)
Pushy investors prime Japan Inc for new phase
Pushy investors prime Japan Inc for new phase
Table: Ajinomoto -2025/26 group results (IFRS)
Table: Ajinomoto -2025/26 parent results